Announcing the Impact Program 2026 Cohort

We’re excited to announce the 4 companies joining the Impact Program 2026 Cohort.

The 6-month, in-person program, running from September 2026 to March 2027, provides founders working on system-level challenges across materials, health, energy, and food, with the dedicated space and support to build traction on their ideas.

Meet the Impact Program 2026 cohort:

Fermii is using fermentation science to develop products for people navigating metabolic health shifts, such as GLP-1 use or perimenopause. (Founders: Anna Tao, Dr Mya Myintzu Hlaing)

Actimo Labs is building protein-protein interactions models through machine learning to help biopharmaceutical companies develop better protein therapeutics. (Founders: Kailash Kumar Vinu, Jaber Jaber, Harshad Vadakkepura, Harjas Gill)

DyNati Energie is developing safe, non-flammable sodium batteries for high-temperature environments where lithium-ion falls short. (Founders: Timothy Khoo, Maria Forysth, Patrick Howlett, Robert Kerr)

Celiva is using saliva-based immune and microbiome signals to improve detection and management of coeliac disease, and other autoimmune conditions. (Founders: Tahra Allen, Avi Jayaprabalan, Pranav Kataria, Khiem Nguyen)

Each company will get access to CoLabs lab and office space, hands-on business support, help identifying and applying for funding pathways, and structured guidance across the full arc of early-stage venture development, from business model generation, value proposition design, systems mapping, funding strategy, pitch coaching, materials research, and connection into the CoLabs ecosystem of mentors, members and collaborators.